Isomerase Therapeutics' Corporate Minority - II Round

Isomerase Therapeutics raised a round of funding on August 15, 2016. Investors include NeuroVive.

Isomerase Therapeutics is a drug discovery and development company based in Cambridge, UK, with particular expertise in the discovery and development of optimized microbial natural products. The compa…

Articles about Isomerase Therapeutics' Corporate Minority - II Round: